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the operation. All operations were performed by the same surgical team. The surgical team and biochemical analysts were unaware of the patients' medications. Preoperatively, the patients were randomly divided into 2 groups: (1) study group (Group T; 2 women, 10 men) received trimetazidine po 60 mg/day for 2 weeks preoperatively and (2) control group (Group C; 3 women, 9 men) that did not received any the medication preoperatively. Four patients in the study group and 3 in the control group had a previous MI more than 6 weeks prior to the present study.
Each patient was monitored with a radial arterial line and a pulmonary artery catheter. They were anesthetized with sufentanil and the surgical procedure was median sternotomy with placement of internal mammary artery and saphenous vein grafts. CPB was performed with a membrane oxygenator and a roller pump maintaining the arterial partial oxygen pressure levels between 150 and 250 mmHg. Heparin was given before cannulation of the aorta (3 mg/kg). Activated clotting time was higher than 400 s in all subjects. Patient temperature was reduced to 30-32°C. The mean flow rate was approximately 2.4 L·min -1 ·m -2 . Antegrade blood cardioplegia was administered to all patients: 1,000 ml initially and repeated in 20 min.
Hemodynamic Measurements
Standard radial arterial, central venous and Swan-Ganz catheters were inserted preoperatively. Hemodynamic parameters were measured before the operation (H0), just after CPB (H1), and at 1 (H2) and 16 (H3) h after CPB using the thermodilution technique (Datascope-Ohmeda (NJ, USA) cardiac monitors).
Metabolic Studies
Serial venous blood samples were collected 2 weeks preoperatively (T0), just before the operation (T1), and at 1 min (T2) and 15 min after release of the cross-clamp (T3). Serum concentrations of SOD, GPx and MDA were measured.
SOD enzyme activity was defined spectrophotometrically (Shimadzu UV-1201, Tokyo, Japan) via the method described by Sun et al 7 and Durak et al. 8 GPx activity was measured by absorbance changes at 340 nm during conversion of NADPH to NADP (Shimadzu UV-1201). MDA generation was evaluated by assay of thiobarbituric acidreacting substances 9 (Shimadzu UV-1201).
Statistical Analysis
Results are expressed as mean ± standard error of the mean. The significance of the difference for these results in the 2 groups was determined using the unpaired Student's t-test. A statistically significant difference was considered if p<0.05.
Results
The clinical and demographic characteristics of the 24 patients are summarized in Table 1 . There were no hospital deaths. There was no significant difference between the 2 groups regarding age, weight, duration of CPB, aortic cross-clamping time, or the number of grafts (p>0.05). There were no significant differences between the groups in the SOD, GPx and MDA values or hemodynamic data at baseline (Table 2) . However, SOD and GPx levels in the study group were significantly higher than those of the control group at T2 (p<0.05 for all) and T3 (p<0.05 for all), but MDA levels in the control group were significantly higher than those of the study group at both these time points. There were no significant differences between the 2 groups in the hemodynamic parameters (p>0.05). In summary, compared with the study group, patients in the control group had higher MDA levels (p<0.05), and reduced activities of antioxidant enzymes such as SOD and GPx (Figs 1,2) .
Discussion
We performed this study in open-heart surgery patients, because the best investigative model of myocardial IR injury is the cardioplegic-arrested heart during heart surgery. Reperfusion of ischemic areas, especially reperfusion with oxygen, may contribute to further to the tissue damage known as reperfusion injury. IR injury causes microvascular damage, reversible contractile dysfunction known as myocardial stunning and in some cases irreversible myocyte damage and finally, reperfusion can cause necrosis of the ischemic myocardium. 10, 11 Many studies have confirmed that IR during heart surgery increases oxygen free radicals and highly active molecules, such as the O2
•-, • OH and H2O2. These radicals have important roles in the microvascular dysfunction of organ disorders and these functional abnormalities can lead to organ death, a consequence of IR injury after cardiac arrest. [12] [13] [14] Increased oxidative stress can also cause oxidation of proteins and lipids, which may lead to molecular and cellular dysfunction. 15 Oxygen free radicals react with polyunsaturated lipids in membranes, creating lipid peroxidation products that can inhibit protein synthesis and alter enzyme activities. Oxidation of polyunsaturated fatty acids of membrane phospholipids can cause membrane disintegration, mitochondrial dysfunction, and Ca 2+ overload. Free radicals react with membrane-bound lipids and lead to lipid peroxidation. CPB is associated with greater than normal lipid peroxidation and with an imbalance in the status of antioxidants. 3 MDA is formed by lipid peroxidation of unsaturated fatty acids and as well as being a marker for oxidative degradation of cellular membranes. It induces a negative cardiac mechanical effect. 16 An increase in the level of antioxidants may make the heart more resistant to IR injury. 17 SOD, GPx, and catalase are the major endogenous antioxidant enzyme systems responsible for limiting intracellular accumulation of oxygen free radicals. 17, 18 Endogenous cardiac antioxidants are oxidized and decreased by IR. 19 SOD is present on the endothelial cell surface and in the cytoplasm and mitochondria, where it catalyzes the dismutation of O2
•-to H2O2 and consequently H2O2 is reduced to H2O and O2. GPx catalyzes the peroxidation of H2O2 in order to form oxidized glutathione and H2O. Use of SOD prevents the IR-induced alterations in cardiac function and thus treatment of the heart with scavengers such as SOD may improve the recovery of cardiac function by protecting the myocardium against IR injury. 20 The administration of antioxidants reduces cardiac cell injury and dysfunction during open heart surgery 21 and during acute MI. 22 SOD may be effective in preventing postpump cardiac dysfunction. GPx is also an important factor in protecting the myocardium from IR injury. The aim of our study was to investigate the effects of trimetazidine on reactive oxygen species that may arise from myocardial IR or systemic inflammation relating to CPB. SOD, reduced glutathione and reduction of oxidative material in the body and the endproduct of lipid peroxidation, MDA, were measured pre and postoperatively as oxidative stress markers (Fig 3) .
Trimetazidine is an anti-ischemic agent and it inhibits the long-chain mitochondrial 3-ketoacyl coenzyme A thiolase enzyme in the myocyte, 23 which in turn causes partial inhibition of fatty acid -oxidation and an increase in glucose oxidation. It increases the antioxidant capacity and protects against oxygen free radical-induced toxicity, 24 counteracts Ca 2+ overload, and reduces the area of necrosis. 25 Trimetazidine is conventionally used mainly for patients with coronary or cerebrovascular disease. It has no effects on coronary flow, contractility, or heart rate, suggesting that it acts by directly improving myocardial energy metabolism. Trimetazidine can bind to mitochondria and it significantly increases the rate of glucose oxidation and reduces the rate of fatty acid oxidation. 26 It is metabolized in the liver and excreted via urine, so patients with renal failure or liver dysfunction were not included in this study.
Pretreatment with trimetazidine was associated with an increase in the major antioxidant enzyme systems, but did not change postoperative hemodynamics. In this study, we found significantly lower MDA and higher SOD and GPx levels in the trimetazidine pretreatment group than in the control group (p<0.05) (Figs 1,2) , which is in accordance with other investigators who showed that trimetazidine was able to obtain the beneficial effect in the reduction of the oxygen free radical. 25 Trimetazidine has an important role in protecting against IR injury by increasing endogenous antioxidants. Some authors found significantly lower cardiac troponin-T levels in the trimetazidine pretreatment group during CABG. 27 We found lower MDA levels in the venous samples from the trimetazidine pretreated group after the release of the crossclamp, which suggest less injury. The increase in endogenous antioxidants and stability of the MDA levels in the systemic venous samples indicate regulation of oxidative stress in the whole body, and may not be directly connected to the heart. Additional studies sampling the coronary sinus blood would be very useful in clarifying this point.
Our study showed that trimetazidine pretreatment scavenged oxygen free radicals, increased the level of SOD and GPx, decreased the level of MDA, and it may reduce IR damage during cardiac surgery, as shown in other studies. 28 In our study MDA levels were significantly decreased in the trimetazidine group. No changes in hemodynamic measurements were recorded, in accordance with results of previous studies. 29 Because of the protective effect of trimetazidine against IR injury, it should be part of the medical treatment protocol before open-heart surgery.
